Term
|
Definition
- Reduction in circulating red blood cell (RBC) mass
- presents with signs and symptoms of hypoxia
- weakness, fatigue and dyspnea
- pale conjunctiva and skin
- headache and lightheadedness
- angina, especially with preexisting coronary artery disease
- Hb, Hct, and RBC are used as surrogates for RBC mass, which is difficult to measure
- Anemeia <13.5 g/dL in males and <12.5 g/dL in females (normal Hb is 13.5-17.5 in males and 12.5-16g/dL in females)
- Based on MCV, anemia can be classified as microcytic (MCV <80 um, normoctic MCV 80-100 um) or macrocytic MCV>100 um)
|
|
|
Term
|
Definition
- MCV <80
- Microcytic anemias are due to decreased prod. of Hb
- RBC progenitor cells in the bone marrow are large and normally divide multiple times to prod. smaller mature cells (MCV=80-100)
- Macrocytosis is due to an extra division which occurs to maintain hemoglobin concetration
- Hemoglobin is made of heme and globin; heme is composed of iron and protoporphyrin. A decrease in any of these components leads to microcytic anemia
- Microcytic anemias inclue 1)iron deficiency anemia 2)anemia of chronic disease 3)Sideroblastic anemia, and 4)Thalassemia
|
|
|
Term
|
Definition
- b/c of decreased levels of iron
- decreased iron-->decreased heme-->decreased hemoglobin-->microcytic anemia
- most common type of anemia since lack of iron is the most common nutritional def. in the world, affecting ~1/3 of world's population
- Iron is consumed in heme (meat-derived) and non-heme (vegetable-derived) forms
- absorption occurs in the duodenum. Enterocytes have heme and non-heme (DMT1) transporters; the heme form is more readily absorbed
- Enterocytes transport iron across the cell membrane into blood via ferroportin
- transferrin transports iron in the blood and delivers it to liver and bone marrow macrophages for storage
- Stored intracellular iron is bound to ferritin, which prevents iron from forming free radicals via the fenton reaction
Lab measurements
- serum iron--measure of iron in the blood
- TIBC-measure of transferrin molecules in the blood
- 3% saturation-percentage of transferrin molecules that are bound by iron (normal is 33%)
- serum ferritin-- reflects iron stores in macrophages and the liver
Caused by:
- Infants-breast-feeding (human milk is low in iron)
- children-poor diet
- adults (20-50 years) peptic ulcer disease in males and menorrhagia or pregnancy in femals
- elderly- colon polyps/carcinoma in the western world; hookworm (ancylostoma duodenale and Necator americanus) in the developing world
- Other causes include malnutrition, malabsorption, and gastrectomy (acid aids iron abs. by maintaining the Fe2+ state, which is more readily absorbed than Fe3+)
Stages of Iron Def
- Storage iron is depeleted-->decreased ferritin: Increased TIBC
- decreased serum iron-->decreased serum iron and decreased % saturation
- Normocytic anemia-- Bone marrow makes fewer, but normal sized, RBCs
- Microcytic, hypochromic anemia--bone marrow makes smaller and fewer RBCs
Clinical findings:anemia, koilonychia , and pica
Lab findings:
- Microcytic, hypochromic RBCs with increased RBC distribution width
- decreased ferritin; increased TIBC; decreased serum iron; decreased % saturation
- Increased Free erythrocyte protoporphyrin (FEP)
- Treatment involves supplemental iron (ferrous sulfate
- Plummer-Vinson Syndrome is iron deficiency anemia w/ esophageal web and atrophic glossitis; presents with anemia, dysphagia, and beefy-red tongue
|
|
|
Term
What is RDW? (Red cell distribution width?) |
|
Definition
- Red cell distribution width (abbreviated as RDW) is a measurement of the amount that red blood cells vary in size. Red blood cells help carry oxygen in the blood.
- This is not the width of the RBC! (that is measured with the MCV)
- A high RDW (over 14.5%) means that the red blood cells vary a lot in size. There are many possible reasons why the RDW level can be too high. (
|
|
|
Term
Anemia of Chronic disease |
|
Definition
- Anemia associated with chronic inflammation (ex endocarditis or autoimmune conditions) or cancer; most common type of anemia in hospitalized patients
- Chronic disease results in production of acute phase reactants from the liver, including hepcidin
- Hepcidin sequesters iron in storage sites by 1) limiting iron transfer from macrophages to erythroid precursors and 2) suppressing erythropoietin(EPO)production; aim is to prevent bacteria from accessing iron, which is necessary for their survival
- a decrease in available iron--> decrease in heme-->decrease in hemoglobin-->microcytic anemia
- Lab. findings include:
- Increased ferritin, decreased TIBC, decreased serum iron, and decreased % saturation
- Increased free erythrocyte protoporphyrin (FEP)
- Treatment involves addressing the underlying cause; exogenous EPO is useaful in a subset of patients, especially those with cancer
|
|
|
Term
|
Definition
- Anemia due to defective protoporphyrin synthesis
- decreased protoporphyrin-->decreased heme-->decreased hemoglobin-->microcytic anemia
- Protoporphyrin is synthesized via a series of reactions
- Aminolevulinic acid synthtase (ALAS) converts succinyl CoA to aminolevulinic acid (ALA) using vitamin B6 as a cofactor (rate limiting step)
- Aminolevulinic acid dehydrogenase (ALAD) converts ALA to porphobilinogen
- Additional reactions converts porphobilinogen to protoporphyrin
- Ferrochelatase attaches protoporphyrin to iron to make heme (final reaction: occurs in the mitochondria)
- Iron is transferred to erythroid precurors and enters the mitochondria to form heme. If protoporphyrin is deficient, iron remains trapped in mitochondria.
- Iron-laden mitochondria form a ring around the nucleus of erythroid precursors; these cells are called ringed sideroblasts (hence the term sideroblastic anemia)
- Sideroblastic anemia can be congenital or acquired.
- Congenital defect most commonly involves ALS (rate-limiting enzymes)
- Acquired causes incled--Alcoholism--Mitochondrial poison
- Lead poisoning- Inhibits ALAD and ferrochelatase
- Vitamin B6 def.-- Required cofactor for ALAS; most commonly seen as a side effect of isoniazid treatment for TB
- Lab. findings include increased ferritin, decreased TIBC, increased serum iron, and increased % saturation (iron overloaded state)
|
|
|
Term
|
Definition
- Anemia due to decreased synthesis of the globin chains of hemoglobin
- decreased globin-->decreased Hb-->microcytic anemia
- Inherited mutation; carriers are protected against Plasmodium falciparum malaria
- Divided into alpha and beta thalassemia based on decreased prod. of alpha or beta globin chains
- Normal types of Hb are HbF (alpha 2 gamma 2), HbA (alpha 2 beta 2) and HbA2 (alpha 2, delta 2)
|
|
|
Term
|
Definition
- Due to gene deletion; normally, 4 alpha genes are present on chromosome 16
- one gene deleted=asymptomatic
- two genes deleted-mild anemia with increased RBC count; cis deletion is assoc. w/ an increased risk of sever thalassemia in offspring
- Cis deletion is when both deletions occur on the same chromosome, seen in asians
- trans deletions is when one deletion occurs on each chromosome; seen in Africans, including African Americans
- 3 genes deleted-- sever anemia; beta chains form tetramers (HbH) that damage RBCs; HbH is seen on electrophoresis
- Four genes deleted--lethal in utero (hyrops fetalis) gamma chains form tetramers (Hb Barts) that damage RBCs; Hb Barts is seen on electrophoresis
|
|
|
Term
|
Definition
- Usually due to gene mutations (point mutations in promotor or splicing sites); seen in individuals of African and Mediterranean descent
- Two beta genes are present on chromosome 11; mutations result in absent (beta o) or diminished Beta + production of the beta/globin chain
|
|
|
Term
|
Definition
- (Beta/Beta + is the mildest form of disease and is usually asymptomatic with an increased RBC count.
- Microcytic, hypochromic RBCs and targe cells are seen on blood smear
- Hemoglobin electrophoresis shows slightly decreased HbA with increased HbA2 (5%, normal 2.5 %) and HbF (2%, normal 1%)
|
|
|
Term
|
Definition
- Beta o/Beta o is the most severe form of disease and presents with severe anemia a few months after birth. High birth HbF (alpha 2, gamma 2) at birth is temporarily protective
- Alpha tetramers aggregate and damage RBCs, resulting in ineffective erythropoiesis and extravascular hemolysis (removal of circulating RBCs by the spleen).
- Massive erythroid hyperplasia ensues resulting in 1)expansion of hematopoiesis into the skull (reactive bone formation leads to crewcut appearance on xray, and facial bones (chipmunk facies).
- Extramedullary hematopoiesis with hepatosplenomegaly,
- risk of aplastic crisis with parvovirus B19 infection of erythropoid precursors
- Chronic transfusions are often necessary; leads to risk for secondary hemochromatosis
- smear shows microcytic, hypochromic RBCs w/ target cells and nucleated RBCs
- Electrophoresis shows little or no HbA with increased HbA2 and HbF
|
|
|
Term
|
Definition
- Anemia with MCV >100 um; most commonly due to folate or vitamin B12 def. (megaloblastic anemia)
- folate and vitamin B12 are nec. for syn. of DNA precursors
- Folate circulates in the serum as methyltetrahydrofolate (Methyl THF); removal of the methyl group allows for participation in the synthesis of DNA precursors
- Methyl group is transferred to vitamin B12 (cobalamin)
- Vitamin b12 then transfers it to homocysteine, producing methionine
- Lack of folate or vitamin B12 impairs synthesis of DNA precursors
- Impaired division and enlargement of RBC precursors leads to megaloblastic anemia
- Impaired division of granulocytic precursors leads to hypersegmented neutrophils
- MEgaloblastic change is also seen in rapidly-dividing (ex intestinal) epithelia cells
- Other causes of macrocytic anemia (w/o megaloblastic change) include alchoholism, liver disease, and drugs
|
|
|
Term
|
Definition
- Dietary folate is obtained from green vegetables and some fruits
- absorbed in the jejunum
- Folate def. develops w/i months, as body stores are minimal
- causes include poor diet (ex alcoholics and elderly), increased demand (ex pregnancy, cancer, and hemolytic anemia), and folate antagonists (e.g. methotrexate, which inhibits dihydrofolate reductase)
- Clinical and laboratory findings include
- Macrocytic RBCs and hypersegmented neutrophils (>5 lobes)
- Glossitis
- Decreased serum folate
- Increased serum homocysteine (increases risk for thrombosis)
- Normal methylmalonic acid
|
|
|
Term
|
Definition
- Dietary B12 is complexed to animal-derived proteins
- Salivary gland enzymes eg amylase liberate vitamin B12, which is then bound by R0binder (Also from the salivary gland) and carried through the stomach
- pancreatic proteases in the duodenum detach vitamin B12 from R-binder
- Vitamin B12 binds intrinsic factor (made by gastric parietal cells) in the small bowel; the intrinsic factor-vitamin B12 complex is absorbed in the ileum
- Vitamin b12 deficiency is less common than folate deficiency and takes years to develop due to large hepatic stores of vitamin B12
- Pernicious anemia is the most common cause of vitamin B12 def.--autoimmune destruction of parietal cells (body of stomach) leads to intrinsic factor deficiency
- Other causes of vitamin B12 def. include pancreatic insufficiency and damage to teh terminal ileum (ex Crohn disease or Diphyllobothrium latum [fish tapeworm] dietary def. is rar, except in vegans
- Clinical and lab findings include
- Macrocytic RBCs w/ hypersegmented neutrophils
- Glossitis
- Subacute combined degeneration of the spinal cord
- Vitamin B12 is a cofactor for the conversion of methylmalonic acid to succinyl CoA (imp. in fatty acid metabolism)
- Vitamin B12 def. results in increased levels of methylmalonic acid which impairs spinal cord myelinization
- Damage results in poor proprioception and vibratory sensation (posterior column) and spastic paresis (lateral corticospinal tract)
- decreased serum vitamin B12
- increased serum homocysteine( similar to folate def.), which increases risk for thrombosis
- Increased methylmalonic acid (unlike folate def)
|
|
|
Term
|
Definition
- Anemia w/ normal sized RBCs (MCV=80-100um^3)
- Due to increased peripheral destruction or underproduction
- Reticulocyte count helps to distinguish between these two etiologies
|
|
|
Term
|
Definition
- Young RBCs released from the bone marrow
- identified on blood smear as larger cells with bluish cytoplasm (due to residual DNA)
- Normal reticulocyte count (RC) is 1-2%
- RBC lifespan is 120 days; each day roughly 1-2 % of RBCs are removed from circulation and replaced by reticulocytes
- A properly functioning marrow responds to anemia by increasing the RC to >3%
- RC, however is falsly elevated in anemia.
- RC is measured as a percentage of total RBCs; decrease in total RBCs falsly elevates percentage of reticulocytes
- RC is corrected by multiplying reticulocyte count by Hct/45
- Corrected count >3% incdicated good marrow response and suggests peripheral destruction
- Corrected count <3% indicates poor marrow response and suggests underproduction
|
|
|
Term
|
Definition
- Autosomal recessive mutation in beta chain of hemoglobin; a single amino acid change replaces normal glutamic acid (hydrophilic) with valine (hydrophobic)
- gene is carried by 10% of individuals of African descent, likely due to protective role against falciparum malaria
- Sickle cell disease arises when two abnormal beta genes are present; results in >90 % HbS in RBCs
- HbS polymerizes when deoxygenated; polymers aggregat into needle-like structures, resulting in sickle cells
- Increased risk of sickling occurs with hypoxemia, dehydration, and acidosis
- HbF protects against sickling; high HbF at birth is rprotective for the first few motnhs of life. Treatment with hydroxyurea increases levels of HbF
- Cells continuously sickle and de-sickle while passing through the microcirculation, resulting in complications related to RBC membrane damage
- Extravascular hemolysis- Reticuloendothelial system removes RBCs with dmaged membranes, leading to anemia, jaundice w/ unconjugated hyperbilirubinemia, and increased risk for bilirubin gallstones
- Intravascular hemolysis-- RBCs with damage membranes dehydrate, leading to hemolysis with decreased haptoglobin and target cells on blood smear
- massive erythroid hyperplasia ensues resulting in :
- expansion of hematopoiesis into the skull and facial bone (crewcut and chipmunk face)
- Extramedullary hematopoiesis with hepatomegaly
- risk of aplastic crisis w/ parvovirus B19 infection of erythroid precursors
- Irreversible sickling leads to complications of vaso-occlusion
- Dactylitis-swollen hands and feet due to vaso-occlusive infarcts in bone; common presenting sign in infants
- autosplenectomy-shrunken, fibrotic splee. Consequences include:
- Increased risk of infection with encapsulated organisms such as streptococcus pneumoniae and Haemophilus influenzae (most common cause of death in children); affected children should be vaccinated by 5 years of age
- increased risk of Salmonella paratyphi osteomyelitis
- Howell-Jolly bodies on blood smear
- Acute chest syndrome-- Vaso-occlusion in pulmonary microcirculation
- presents with chest pain, shortness of breath, and lung infiltrates
- often precipitated by pneumonia
- most common cause of death in adults
- Pain crisis
- Renal papillary necrosis-results in gross hematuria and proteinuria
- Sickle cell trait is the presence of one mutated and one normal beta chain; results in <50% HbS in RBCs (HbA is slightly more eff prod. than HbS)
- Generally asymptomatic w/ no anemia; RBCs w/ <50% HbS do not sickle in vivo except in the renal medulla
- Extreme hypoxia and hypertonicity of the medulla cause sickling, which results in microinfarctions leading to microscopic hematuria and, eventually decreased ability to concentrate urin
Lab findings:
- Sickle Cells and target cells are seen on blood smear in sickle cell disease, but no in sickle cell trait
- metabisulfate screen causes cells w/ any amt of HbS to sickle; positive to both disease and trait
- Hb electrophoresis confirms the presence and amt of Hb S
- Disease 90% HbS, 8% HbF, 2% HbA2 (No Hb A)
- Trait 55% HbA, 43% HbS, 2% HbA2
|
|
|
Term
Peripheral RBC destruction (hemolysis) |
|
Definition
- Divided into extravascular and intravascular hemolysis; both result in anemia w/ a good marrow response
- Extravascular hemolysis involves RBC destruction by the reticuloendothelial system (macrophages of the spleen, liver and lymphy nodes)
- macrophages consume RBCs and break down hemoglobin
- globin is broken down into AAs
- heme is broken down into iron and protoporphyrin; iron is recycled
- protoporphyrin is broken down into unconjugated bilirubin, which is bound to serum albumin and delivered to the liver for conjugation and excretion into bile
- clin and lab findings:
- Hemoglobinemia
- Hemoglobinuria
- hemosiderinuria-Renal tubular cells pick up some of the hemoglobin that is filtered into the urine and break it down into iron, which accumulates as hemosiderin; tubular cells are eventually shed resulting in hemosiderinuria
- decreased serum haptoglobin
|
|
|
Term
Anemia due to Underproduction |
|
Definition
- Basic Principles
- Decreased prod. of RBCs by bone marrow; char by low corrected reticulocyte count
- Etiologies include:
- causes of microcytic and macrocytic anemia
- Renal failure-decreased prod. of EPO by peritubular interstitial cells
- Damage to bone marrow precuros cells (may result in anemia or pancytopenia)
|
|
|
Term
|
Definition
- Inherited defect of RBC cytoskeleton-membrane tetherine proteins
- Mostcommonly involves spectrin, ankyrin, or band 3.1
- Membrane blebs are formed and lost over time
- Loss of membrane renders cells round (spherocytes) instead of disc-shaped
- spherocytes are less able to maneuver through splenic sinusoids and are consumbed by splenic macrophages, resulting in anemia
- Clinical and lab findings include
- spherocytes w/ loss of central pallow
- increased RDW adn increased mean corpuscular hemoglobin concentration (MCHC)
- splenogmegaly, jaundice with unconjugated bilirubin, and increased risk for bilirubin gallstones (Extravascular hemolysis)
- increased risk for aplastic crisis with parvovirus B19 infection of erythroid precursors
- Diagnosed by osmotic fragility test, which reveals increased spherocyte fragility in hypotonic solution
- Treatment is splenectomy; anemia resolves, but spherocytes persist and Howell-Jolly Bodies (Fragments of nuclear material in RBCs emerge on blood smear)
|
|
|
Term
|
Definition
- Autosomal recessive mutation in beta chain of hemoglobin
- Normal glutamic acid is replaced by lysine
- less common than sickle cell disease
- presents with mild anemia due to extravascular hemolysis
- Char. HbC crystals are seen in RBCs on blood smear
|
|
|
Term
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Definition
- Acquired defect in myeloid stem cells resulting in absent glycosylphosphatidylinositol (GPI); renders cells susceptible to destruction by complement
- Blood cells coexist with complement
- decay accelerating factor (DAF) on the surface of blood cells protects agains complement-mediated damage by inhibiting C3 convertase
- DAF is secured to the cell membrane by GPI (an anchoring protein)
- Absence of GPI leads to absence of DAF, rendering cells susceptible to complement-mediated damage
- Intravascular hemolysis leads to hemoglobinemia and hemoglobinuria (esp. in the morning) hemosiderinuria is seen days after hemolysis
- sucrose test is used to screen for disease; confirmatory test is the acidified serum test or flow cytometry to detect lack of CD55 (DAF) on blood cells
- Main cause of death is thrombosis of the hepatic, portal, or cerebral veins
- Destroyed platelets release cytoplasmic contents into circulation, inducing thrombosis
- Complications include iron def. anemia (due to chronic loss of hemoglobin in the urine) and acute myeloid leukemia (AML), which develops in 10% of patients
|
|
|
Term
Glucose 6 phosphate Dehydrogenase G6PD def |
|
Definition
- X linked recessive disorder resulting in reduced 1/2 life of G6PD; renders cells susceptible to oxidative stress
- RBCs are normall exposed to oxidative stress, in particular H2O2
- Glutathione (an antioxidant) neutralizes H2O2, but becomes oxidized in the process
- NADPH, a by product of G6PD, is needed to regenerate reduced glutathione
- Decreased G6PD-->decreased NADPH-->reduced glutathione-->oxidative injurty by H2O2-->intravascular hemolysis
- G6PD has 2 variants
- African variant-mildly reduced t1/2 of G6PD leading to mild intravascular hemolysis with oxidative stress
- Mediterranean variant-markedly reduced half life of G6PD leading to marked intravascular hemolys with oxidative stress
- High carrier frequency in both populations is likely due to protective role against falciparum malaria
- Oxidative stress precipitates Hb as Heinz bodies
- causes of oxidative stress include infections, drugs (ex primaquin, sulfa drugs, and dapsone), and fava beans
- Heinz bodies are removed from RBCs by splenic macrophages, resultin in bite cells
- leads to pred. intravascular hemolysis
- Presents with hemoglobinuria and back pain hours after exposure to oxidative stress
- Heinz preparation is used to screen for disease (precipitated hemoglobin can only be seen w/ a special heinz stain)
- Enzyme studies confirm def. (performed weeks after hemolytic episode resolves)
|
|
|
Term
Immune Hemolytic Anemia (IHA) |
|
Definition
- Antibody-mediated (IgG or IgM) destruction of RBCs
- IgG-mediated disease usually involves extravascular hemolysis
- IgG binds RBCs in the relatively warm temperature of the central body (warm agglutinin); membrane of antibody-coated RBC is consumed by splenic macrophages resulting in spherocytes
- Associated w/ SLE (most common cause), CLSS, and certain drugs (classically penicillin and cephalosporins)
- Drug may attach to RBC membrane (ex peniclillin) w/ subseqent binding of antibody to drug membrane-complex
- Drug may induce prod. of autoantibodies (ex alpha methyldopa) that bind self antigens on RBCs
- Treatment involves cessation of the offending drug, steroids, IVIG, and if necessary, splenectomy.
- IgM-mediated disease usually involves intravascular hemolysis
- IgM binds RBCs and fixes complement in the relatively cold temperature of the extremeties (cold agglutinin)
- Associated w/ Mycoplasma Pneumonia and infectious mononucleosis
- Coombs test is used to diagnose IHA; testing can be direct or indirect
- Direct Coombs test confirms the presnec of antibody-coated RBCS, Anti-IgG is added to patient RBCS, agglutination occurs if RBCs are already coated w/ antibody. This is the most important test for IHA
- Indirect Coombs test confirms the presence of antibodies in patient serum. Anti-IgG and test RBCs are mixed with the patient serum; agglutination occurs if serum antibodies are present
|
|
|
Term
Microangiopathic Hemolytic Anemia |
|
Definition
- Intravascular hemolysis that results from vascular pathology; RBCs are destroyes as they pass through the circulation
- Iron def. Anemia occurs with Chronic hemolysis
- Occurs with microthrombi (TTP-HUS, DIC, HELLP), prosthetic heart valves and aortic stenosis, microthrombi produce schistocytes on blood smear
|
|
|
Term
|
Definition
- Infection of RBCs and liver with Plasmodium; transmitted by the female Anopheles mosquito
- RBCs rupture as a pare of the plasmodium life cycle, resulting in intravascular hemolysis and cyclical fever
- P. falciparum-daily fever
- P vivax and P ovale-- fever every other day
- Splee also consumes some infected RBCs; results in mild extravascular hemolysis w/ splenomegaly
|
|
|
Term
|
Definition
Pathologic process (ex metastatic cancer) that replaces bone marrow; hematopoiesis is impaired, resulting in pancytopenia |
|
|
Term
|
Definition
- Infects progenitor red cells and temporarily halts erythropoiesis; leads to sig. anemia in the setting of preexisting marrow stress (ex sickle cell anemia)
- Treatment is supportive (infection is self-limited)
|
|
|
Term
|
Definition
- Damage to hematopoietic stem cells, resulting in pancytopenia (anemia, thrombocytopenia, and leukopenia) with low reticulocyte count
- Etiologies include drugs or chemicals, viral infections, and autoimmune damage
- Biopsy reveals an empty, fatty marrow
- Treatment includes cessation of any causative drugs and supportive care w/ transfusions and marrow-stimulating fators (ex erythropoietin, GM-CSF, and G-CSF)/
- Immunosuppression may be helpful as some idiopathic cases are due to abn. T-cell act. w/ release of cytokines
- May req. bone marrow transplantation as a last resort
|
|
|